Taiwan FDA registration 7d3cfbe36f2bad13c0ada5bf2ad70fbc
“AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System
TW: “艾翠科” 左心耳閉塞夾系統
Taiwan·Risk Class 2·MD·Atricure, Inc.·Registered Apr 09, 2021 – Apr 09, 2026ExpiredRegistration details
- Analysis ID
- 7d3cfbe36f2bad13c0ada5bf2ad70fbc
- License Form
- Ministry of Health Medical Device Import No. 034494
- Customs Code
- DHA05603449403
Company information
- Manufacturer
- Atricure, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- ASIA HEALTH CARE CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E9999 Other
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 09, 2021
- Expiry Date
- Apr 09, 2026
About this record
Access comprehensive regulatory information for “AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7d3cfbe36f2bad13c0ada5bf2ad70fbc and manufactured by Atricure, Inc.. The authorized representative in Taiwan is ASIA HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices